University Of Vermont Medical Center

This study is testing if changing the timing of two common chemotherapy drugs (capecitabine and oxaliplatin) causes fewer and less severe side effects for people with gastrointestinal cancers. The goal is to see if this modified schedule is easier for patients to tolerate than th…

This study is testing a new support program for adults who have inherited gene changes that increase their cancer risk, especially those living in rural areas. The program provides personalized care plans and regular check-ins over two years to help participants follow recommende…